A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

NCT00477581 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide
DRUG: sitagliptin

Sponsor

AstraZeneca

Collaborators

[object Object]